Watch the Dallas Symposium LIVE, and fundraiser auction
Ticket proceeds support mindat.org! - click here...
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2013, May) Reactions Weekly Vol. 1451 (1) Springer Science and Business Media LLC

Advanced
   -   Only viewable:
Reference TypeJournal (issue)
JournalReactions Weekly
Year2013 (May)Volume1451
Issue1
PublisherSpringer Science and Business Media LLC
Mindat Ref. ID13302406Long-form Identifiermindat:1:5:13302406:9
GUID0
Full Reference(2013, May) Reactions Weekly Vol. 1451 (1) Springer Science and Business Media LLC
Plain Text(2013, May) Reactions Weekly Vol. 1451 (1) Springer Science and Business Media LLC
In(2013) Reactions Weekly Vol. 1451. Springer Science and Business Media LLC

Contains

(2013) Improved contraceptive counselling needed with MTX use. Reactions Weekly, 1451 (1) 1 doi:10.1007/s40278-013-2874-7
(2013) Perioperative SSRI use increases risk of adverse outcomes. Reactions Weekly, 1451 (1) 1 doi:10.1007/s40278-013-2875-6
(2013) Analgesics before endurance sport increase risk of adverse events. Reactions Weekly, 1451 (1) 2 doi:10.1007/s40278-013-2876-5
(2013) At-home med errors common among kids with cancer. Reactions Weekly, 1451 (1) 2 doi:10.1007/s40278-013-2877-4
(2013) Guillain-Barré syndrome not associated with vaccination. Reactions Weekly, 1451 (1) 3 doi:10.1007/s40278-013-2878-3
(2013) FDA warns of potential confusion with name of new cancer drug. Reactions Weekly, 1451 (1) 3 doi:10.1007/s40278-013-2879-2
(2013) Azithromycin and CV mortality risk in a general population. Reactions Weekly, 1451 (1) 3 doi:10.1007/s40278-013-2880-9
(2013) Vigibase grows to 8 million reports. Reactions Weekly, 1451 (1) 4 doi:10.1007/s40278-013-2881-8
(2013) Propylthiouracil use and serious skin reactions. Reactions Weekly, 1451 (1) 4 doi:10.1007/s40278-013-2882-7
(2013) EMA provides first details of its reorganisation. Reactions Weekly, 1451 (1) 4 doi:10.1007/s40278-013-2883-6
(2013) EMA publishes list of meds under close watch. Reactions Weekly, 1451 (1) 4 doi:10.1007/s40278-013-2884-5
(2013) Pradaxa label warns of stroke risks following discontinuation. Reactions Weekly, 1451 (1) 4 doi:10.1007/s40278-013-2885-4
(2013) Alemtuzumab. Reactions Weekly, 1451 (1) 5 doi:10.1007/s40278-013-2886-3
(2013) Adalimumab. Reactions Weekly, 1451 (1) 5 doi:10.1007/s40278-013-2887-2
(2013) 4-amino-3-phenylbutyric acid. Reactions Weekly, 1451 (1) 5 doi:10.1007/s40278-013-2888-1
(2013) Adefovir dipivoxil. Reactions Weekly, 1451 (1) 5 doi:10.1007/s40278-013-2889-0
(2013) Amiodarone. Reactions Weekly, 1451 (1) 6 doi:10.1007/s40278-013-2890-7
(2013) Amiodarone. Reactions Weekly, 1451 (1) 6 doi:10.1007/s40278-013-2891-6
(2013) Alteplase. Reactions Weekly, 1451 (1) 6 doi:10.1007/s40278-013-2892-5
(2013) Antineoplastics. Reactions Weekly, 1451 (1) 7 doi:10.1007/s40278-013-2893-4
(2013) Amodiaquine/artesunate. Reactions Weekly, 1451 (1) 7 doi:10.1007/s40278-013-2894-3
(2013) Antiretrovirals/warfarin interaction. Reactions Weekly, 1451 (1) 7 doi:10.1007/s40278-013-2895-2
(2013) Amlodipine. Reactions Weekly, 1451 (1) 7 doi:10.1007/s40278-013-2896-1
(2013) Amphotericin B. Reactions Weekly, 1451 (1) 7 doi:10.1007/s40278-013-2897-0
(2013) Amiodarone. Reactions Weekly, 1451 (1) 7 doi:10.1007/s40278-013-2898-z
(2013) Arsenic trioxide. Reactions Weekly, 1451 (1) 8 doi:10.1007/s40278-013-2899-y
(2013) Aspirin. Reactions Weekly, 1451 (1) 8 doi:10.1007/s40278-013-2900-9
(2013) Antituberculars. Reactions Weekly, 1451 (1) 8 doi:10.1007/s40278-013-2901-8
(2013) Asparaginase. Reactions Weekly, 1451 (1) 8 doi:10.1007/s40278-013-2902-7
(2013) Aripiprazole/risperidone. Reactions Weekly, 1451 (1) 8 doi:10.1007/s40278-013-2903-6
(2013) Aspirin withdrawal. Reactions Weekly, 1451 (1) 9 doi:10.1007/s40278-013-2904-5
(2013) Atorvastatin/ranolazine interaction. Reactions Weekly, 1451 (1) 9 doi:10.1007/s40278-013-2905-4
(2013) Atorvastatin. Reactions Weekly, 1451 (1) 9 doi:10.1007/s40278-013-2906-3
(2013) Aspirin/warfarin. Reactions Weekly, 1451 (1) 9 doi:10.1007/s40278-013-2907-2
(2013) Atropine/homatropine/phenylephrine. Reactions Weekly, 1451 (1) 10 doi:10.1007/s40278-013-2908-1
(2013) BCG vaccine. Reactions Weekly, 1451 (1) 10 doi:10.1007/s40278-013-2909-0
(2013) BCG. Reactions Weekly, 1451 (1) 10 doi:10.1007/s40278-013-2910-7
(2013) Bleomycin. Reactions Weekly, 1451 (1) 11 doi:10.1007/s40278-013-2911-6
(2013) Bevacizumab. Reactions Weekly, 1451 (1) 11 doi:10.1007/s40278-013-2912-5
(2013) Bevacizumab/erlotinib. Reactions Weekly, 1451 (1) 11 doi:10.1007/s40278-013-2913-4
(2013) Bevacizumab. Reactions Weekly, 1451 (1) 11 doi:10.1007/s40278-013-2914-3
(2013) Bupropion. Reactions Weekly, 1451 (1) 12 doi:10.1007/s40278-013-2915-2
(2013) Bleomycin. Reactions Weekly, 1451 (1) 12 doi:10.1007/s40278-013-2916-1
(2013) BV NSCLC 001. Reactions Weekly, 1451 (1) 12 doi:10.1007/s40278-013-2917-0
(2013) Bromocriptine. Reactions Weekly, 1451 (1) 12 doi:10.1007/s40278-013-2918-z
(2013) Capecitabine/lapatinib. Reactions Weekly, 1451 (1) 13 doi:10.1007/s40278-013-2919-y
(2013) Calcium carbonate/valsartan/hydrochlorothiazide/vitamin D. Reactions Weekly, 1451 (1) 13 doi:10.1007/s40278-013-2920-5
(2013) Capsaicin. Reactions Weekly, 1451 (1) 13 doi:10.1007/s40278-013-2921-4
(2013) Carbamazepine. Reactions Weekly, 1451 (1) 14 doi:10.1007/s40278-013-2922-3
(2013) Cetuximab. Reactions Weekly, 1451 (1) 14 doi:10.1007/s40278-013-2923-2
(2013) Carbamazepine. Reactions Weekly, 1451 (1) 14 doi:10.1007/s40278-013-2924-1
(2013) Carboplatin/docetaxel. Reactions Weekly, 1451 (1) 14 doi:10.1007/s40278-013-2925-0
(2013) Carbamazepine/methotrexate. Reactions Weekly, 1451 (1) 14 doi:10.1007/s40278-013-2926-z
(2013) Clozapine. Reactions Weekly, 1451 (1) 15 doi:10.1007/s40278-013-2927-y
(2013) Ciprofloxacin. Reactions Weekly, 1451 (1) 15 doi:10.1007/s40278-013-2928-x
(2013) Cisplatin/docetaxel/fluorouracil. Reactions Weekly, 1451 (1) 15 doi:10.1007/s40278-013-2929-9
(2013) Clozapine. Reactions Weekly, 1451 (1) 15 doi:10.1007/s40278-013-2930-3
(2013) Clarithromycin/colchicine interaction. Reactions Weekly, 1451 (1) 15 doi:10.1007/s40278-013-2931-2
(2013) Cytarabine. Reactions Weekly, 1451 (1) 16 doi:10.1007/s40278-013-2932-1
(2013) Dabigatran etexilate. Reactions Weekly, 1451 (1) 16 doi:10.1007/s40278-013-2933-0
(2013) Dabigtran etexilate. Reactions Weekly, 1451 (1) 16 doi:10.1007/s40278-013-2934-z
(2013) Daclizumab. Reactions Weekly, 1451 (1) 16 doi:10.1007/s40278-013-2935-y
(2013) Dapsone. Reactions Weekly, 1451 (1) 17 doi:10.1007/s40278-013-2936-x
(2013) Dextromethorphan/doxylamine/paracetamol. Reactions Weekly, 1451 (1) 17 doi:10.1007/s40278-013-2937-9
(2013) Dexamethasone. Reactions Weekly, 1451 (1) 17 doi:10.1007/s40278-013-2938-8
(2013) Diltiazem. Reactions Weekly, 1451 (1) 17 doi:10.1007/s40278-013-2939-7
(2013) Doxorubicin. Reactions Weekly, 1451 (1) 18 doi:10.1007/s40278-013-2940-1
(2013) Doxorubicin/epirubicin. Reactions Weekly, 1451 (1) 18 doi:10.1007/s40278-013-2941-0
(2013) Domperidone. Reactions Weekly, 1451 (1) 18 doi:10.1007/s40278-013-2942-z
(2013) Diphtheria tetanus and pertussis vaccine/influenza virus vaccine. Reactions Weekly, 1451 (1) 18 doi:10.1007/s40278-013-2943-y
(2013) Emtricitabine/vinblastine. Reactions Weekly, 1451 (1) 19 doi:10.1007/s40278-013-2944-x
(2013) Esomeprazole. Reactions Weekly, 1451 (1) 19 doi:10.1007/s40278-013-2945-9
(2013) Enoxaparin sodium. Reactions Weekly, 1451 (1) 19 doi:10.1007/s40278-013-2946-8
(2013) Erlotinib. Reactions Weekly, 1451 (1) 19 doi:10.1007/s40278-013-2947-7
(2013) Etanercept. Reactions Weekly, 1451 (1) 20 doi:10.1007/s40278-013-2948-6
(2013) Etanercept. Reactions Weekly, 1451 (1) 20 doi:10.1007/s40278-013-2949-5
(2013) Etanercept. Reactions Weekly, 1451 (1) 20 doi:10.1007/s40278-013-2950-z
(2013) Esomeprazole/nonsteroidal anti-inflammatories. Reactions Weekly, 1451 (1) 20 doi:10.1007/s40278-013-2951-y
(2013) Etoricoxib/NSAIDs. Reactions Weekly, 1451 (1) 21 doi:10.1007/s40278-013-2952-x
(2013) Etanercept/infliximab. Reactions Weekly, 1451 (1) 21 doi:10.1007/s40278-013-2953-9
(2013) Etanercept/infliximab. Reactions Weekly, 1451 (1) 21 doi:10.1007/s40278-013-2954-8
(2013) Everolimus. Reactions Weekly, 1451 (1) 22 doi:10.1007/s40278-013-2956-6
(2013) Fluconazole. Reactions Weekly, 1451 (1) 22 doi:10.1007/s40278-013-2957-5
(2013) Fluconazole/itraconazole/voriconazole. Reactions Weekly, 1451 (1) 22 doi:10.1007/s40278-013-2958-4
(2013) Garenoxacin. Reactions Weekly, 1451 (1) 23 doi:10.1007/s40278-013-2959-3
(2013) Glibenclamide. Reactions Weekly, 1451 (1) 23 doi:10.1007/s40278-013-2960-x
(2013) Fosinopril/lisinopril/ramipril. Reactions Weekly, 1451 (1) 23 doi:10.1007/s40278-013-2961-9
(2013) Gemifloxacin. Reactions Weekly, 1451 (1) 23 doi:10.1007/s40278-013-2962-8
(2013) Hydroxychloroquine. Reactions Weekly, 1451 (1) 24 doi:10.1007/s40278-013-2963-7
(2013) Heparin. Reactions Weekly, 1451 (1) 24 doi:10.1007/s40278-013-2964-6
(2013) Heparin. Reactions Weekly, 1451 (1) 24 doi:10.1007/s40278-013-2965-5
(2013) Imatinib/nilotinib. Reactions Weekly, 1451 (1) 25 doi:10.1007/s40278-013-2966-4
(2013) Iloperidone. Reactions Weekly, 1451 (1) 25 doi:10.1007/s40278-013-2967-3
(2013) Ibuprofen. Reactions Weekly, 1451 (1) 25 doi:10.1007/s40278-013-2968-2
(2013) Imatinib/nilotinib. Reactions Weekly, 1451 (1) 25 doi:10.1007/s40278-013-2969-1
(2013) Immunosuppressants. Reactions Weekly, 1451 (1) 26 doi:10.1007/s40278-013-2970-8
(2013) Immunosuppressants. Reactions Weekly, 1451 (1) 26 doi:10.1007/s40278-013-2971-7
(2013) Immunosuppressants/voriconazole. Reactions Weekly, 1451 (1) 26 doi:10.1007/s40278-013-2972-6
(2013) Immune globulin. Reactions Weekly, 1451 (1) 26 doi:10.1007/s40278-013-2973-5
(2013) Indigotindisulfonate sodium. Reactions Weekly, 1451 (1) 27 doi:10.1007/s40278-013-2975-3
(2013) Infliximab. Reactions Weekly, 1451 (1) 27 doi:10.1007/s40278-013-2976-2
(2013) Indapamide/ketoprofen/metformin. Reactions Weekly, 1451 (1) 27 doi:10.1007/s40278-013-2977-1
(2013) Infliximab. Reactions Weekly, 1451 (1) 27 doi:10.1007/s40278-013-2974-4
(2013) Infliximab. Reactions Weekly, 1451 (1) 28 doi:10.1007/s40278-013-2978-0
(2013) Insulins. Reactions Weekly, 1451 (1) 28 doi:10.1007/s40278-013-2979-z
(2013) Insulin aspart/insulin glargine/insulin lispro. Reactions Weekly, 1451 (1) 28 doi:10.1007/s40278-013-2980-6
(2013) Influenza virus vaccine. Reactions Weekly, 1451 (1) 28 doi:10.1007/s40278-013-2981-5
(2013) Insulin. Reactions Weekly, 1451 (1) 28 doi:10.1007/s40278-013-2982-4
(2013) Interferon-α-2b. Reactions Weekly, 1451 (1) 29 doi:10.1007/s40278-013-2983-3
(2013) Iodixanol. Reactions Weekly, 1451 (1) 29 doi:10.1007/s40278-013-2984-2
(2013) Interferon-β-1b. Reactions Weekly, 1451 (1) 29 doi:10.1007/s40278-013-2985-1
(2013) Iopromide. Reactions Weekly, 1451 (1) 30 doi:10.1007/s40278-013-2986-0
(2013) Iohexol. Reactions Weekly, 1451 (1) 30 doi:10.1007/s40278-013-2987-z
(2013) Iopamidol. Reactions Weekly, 1451 (1) 30 doi:10.1007/s40278-013-2988-y
(2013) Ipilimumab. Reactions Weekly, 1451 (1) 30 doi:10.1007/s40278-013-2989-x
(2013) Isotretinoin. Reactions Weekly, 1451 (1) 31 doi:10.1007/s40278-013-2990-4
(2013) Isotretinoin. Reactions Weekly, 1451 (1) 31 doi:10.1007/s40278-013-2991-3
(2013) Isoniazid. Reactions Weekly, 1451 (1) 31 doi:10.1007/s40278-013-2992-2
(2013) Ipilimumab. Reactions Weekly, 1451 (1) 31 doi:10.1007/s40278-013-2993-1
(2013) Lamotrigine/valproic acid interaction. Reactions Weekly, 1451 (1) 32 doi:10.1007/s40278-013-2994-0
(2013) Lansoprazole. Reactions Weekly, 1451 (1) 32 doi:10.1007/s40278-013-2995-z
(2013) Ixabepilone. Reactions Weekly, 1451 (1) 32 doi:10.1007/s40278-013-2996-y
(2013) Lacosamide/valproic acid. Reactions Weekly, 1451 (1) 32 doi:10.1007/s40278-013-2997-x
(2013) Levodopa/carbidopa/entacapone. Reactions Weekly, 1451 (1) 33 doi:10.1007/s40278-013-2998-9
(2013) Levodopa/carbidopa. Reactions Weekly, 1451 (1) 33 doi:10.1007/s40278-013-2999-8
(2013) Lenalidomide/pravastatin. Reactions Weekly, 1451 (1) 33 doi:10.1007/s40278-013-3000-6
(2013) Levmetamfetamine. Reactions Weekly, 1451 (1) 33 doi:10.1007/s40278-013-3001-5
(2013) Lithium. Reactions Weekly, 1451 (1) 34 doi:10.1007/s40278-013-3002-4
(2013) Mannitol. Reactions Weekly, 1451 (1) 34 doi:10.1007/s40278-013-3003-3
(2013) Liraglutide. Reactions Weekly, 1451 (1) 34 doi:10.1007/s40278-013-3004-2
(2013) Methotrexate. Reactions Weekly, 1451 (1) 35 doi:10.1007/s40278-013-3005-1
(2013) Methotrexate. Reactions Weekly, 1451 (1) 35 doi:10.1007/s40278-013-3006-0
(2013) Megestrol. Reactions Weekly, 1451 (1) 35 doi:10.1007/s40278-013-3007-z
(2013) Measles and rubella virus vaccine/poliovirus vaccine live oral. Reactions Weekly, 1451 (1) 35 doi:10.1007/s40278-013-3008-y
(2013) Methylprednisolone sodium succinate. Reactions Weekly, 1451 (1) 36 doi:10.1007/s40278-013-3009-x
(2013) Minoxidil. Reactions Weekly, 1451 (1) 36 doi:10.1007/s40278-013-3010-4
(2013) Methylprednisolone acetate. Reactions Weekly, 1451 (1) 36 doi:10.1007/s40278-013-3011-3
(2013) Nilotinib. Reactions Weekly, 1451 (1) 37 doi:10.1007/s40278-013-3012-2
(2013) Moxifloxacin. Reactions Weekly, 1451 (1) 37 doi:10.1007/s40278-013-3013-1
(2013) Mycophenolate mofetil/prednisolone/tacrolimus. Reactions Weekly, 1451 (1) 37 doi:10.1007/s40278-013-3014-0
(2013) Mycophenolate/mycophenolate mofetil/mycophenolate sodium. Reactions Weekly, 1451 (1) 37 doi:10.1007/s40278-013-3015-z
(2013) Nortriptyline. Reactions Weekly, 1451 (1) 38 doi:10.1007/s40278-013-3016-y
(2013) Oxycodone/venlafaxine. Reactions Weekly, 1451 (1) 38 doi:10.1007/s40278-013-3017-x
(2013) Olanzapine/topiramate. Reactions Weekly, 1451 (1) 38 doi:10.1007/s40278-013-3018-9
(2013) Oxaliplatin. Reactions Weekly, 1451 (1) 38 doi:10.1007/s40278-013-3019-8
(2013) Paclitaxel. Reactions Weekly, 1451 (1) 39 doi:10.1007/s40278-013-3020-2
(2013) Panitumumab. Reactions Weekly, 1451 (1) 39 doi:10.1007/s40278-013-3021-1
(2013) Paracetamol. Reactions Weekly, 1451 (1) 39 doi:10.1007/s40278-013-3022-0
(2013) Paracetamol/dextromethorphan/pseudoephedrine. Reactions Weekly, 1451 (1) 39 doi:10.1007/s40278-013-3023-z
(2013) Phenobarbital/phenytoin. Reactions Weekly, 1451 (1) 40 doi:10.1007/s40278-013-3024-y
(2013) Phenytoin. Reactions Weekly, 1451 (1) 40 doi:10.1007/s40278-013-3025-x
(2013) Phenobarbital. Reactions Weekly, 1451 (1) 40 doi:10.1007/s40278-013-3026-9
(2013) Peginterferon-α-2a/ribavirin/telaprevir. Reactions Weekly, 1451 (1) 40 doi:10.1007/s40278-013-3027-8
(2013) Propofol. Reactions Weekly, 1451 (1) 41 doi:10.1007/s40278-013-3028-7
(2013) Propranolol. Reactions Weekly, 1451 (1) 41 doi:10.1007/s40278-013-3029-6
(2013) Propofol. Reactions Weekly, 1451 (1) 41 doi:10.1007/s40278-013-3030-0
(2013) Pneumococcal 13-valent CRM197 vaccine conjugate. Reactions Weekly, 1451 (1) 41 doi:10.1007/s40278-013-3031-z
(2013) Propylthiouracil/thiamazole. Reactions Weekly, 1451 (1) 42 doi:10.1007/s40278-013-3032-y
(2013) Quetiapine/vancomycin. Reactions Weekly, 1451 (1) 42 doi:10.1007/s40278-013-3033-x
(2013) Ranolazine. Reactions Weekly, 1451 (1) 42 doi:10.1007/s40278-013-3034-9
(2013) Quetiapine. Reactions Weekly, 1451 (1) 42 doi:10.1007/s40278-013-3035-8
(2013) Risperidone withdrawal. Reactions Weekly, 1451 (1) 43 doi:10.1007/s40278-013-3036-7
(2013) Salbutamol. Reactions Weekly, 1451 (1) 43 doi:10.1007/s40278-013-3037-6
(2013) Repaglinide. Reactions Weekly, 1451 (1) 43 doi:10.1007/s40278-013-3038-5
(2013) Risperidone. Reactions Weekly, 1451 (1) 43 doi:10.1007/s40278-013-3039-4
(2013) Sevoflurane. Reactions Weekly, 1451 (1) 44 doi:10.1007/s40278-013-3040-y
(2013) Salbutamol. Reactions Weekly, 1451 (1) 44 doi:10.1007/s40278-013-3041-x
(2013) Sodium valproate. Reactions Weekly, 1451 (1) 44 doi:10.1007/s40278-013-3042-9
(2013) Sorafenib. Reactions Weekly, 1451 (1) 44 doi:10.1007/s40278-013-3043-8
(2013) Tacrolimus. Reactions Weekly, 1451 (1) 45 doi:10.1007/s40278-013-3044-7
(2013) Suxamethonium chloride. Reactions Weekly, 1451 (1) 45 doi:10.1007/s40278-013-3045-6
(2013) Sulfacetamide. Reactions Weekly, 1451 (1) 45 doi:10.1007/s40278-013-3046-5
(2013) Tamoxifen. Reactions Weekly, 1451 (1) 45 doi:10.1007/s40278-013-3047-4
(2013) Telaprevir. Reactions Weekly, 1451 (1) 46 doi:10.1007/s40278-013-3048-3
(2013) Tigecycline. Reactions Weekly, 1451 (1) 46 doi:10.1007/s40278-013-3049-2
(2013) Testosterone. Reactions Weekly, 1451 (1) 46 doi:10.1007/s40278-013-3050-9
(2013) Tenofovir disoproxil fumarate. Reactions Weekly, 1451 (1) 46 doi:10.1007/s40278-013-3051-8
(2013) Tetryzoline. Reactions Weekly, 1451 (1) 46 doi:10.1007/s40278-013-3052-7
(2013) Valproic acid. Reactions Weekly, 1451 (1) 47 doi:10.1007/s40278-013-3053-6
(2013) Varenicline. Reactions Weekly, 1451 (1) 47 doi:10.1007/s40278-013-3054-5
(2013) Tocilizumab. Reactions Weekly, 1451 (1) 47 doi:10.1007/s40278-013-3055-4
(2013) Topotecan. Reactions Weekly, 1451 (1) 47 doi:10.1007/s40278-013-3056-3
(2013) Vemurafenib. Reactions Weekly, 1451 (1) 48 doi:10.1007/s40278-013-3057-2
(2013) Vemurafenib. Reactions Weekly, 1451 (1) 48 doi:10.1007/s40278-013-3058-1
(2013) Verapamil. Reactions Weekly, 1451 (1) 48 doi:10.1007/s40278-013-3059-0
(2013) Vinpocetine. Reactions Weekly, 1451 (1) 48 doi:10.1007/s40278-013-3060-7
(2013) Vemurafenib. Reactions Weekly, 1451 (1) 48 doi:10.1007/s40278-013-3061-6
(2013) Warfarin. Reactions Weekly, 1451 (1) 49 doi:10.1007/s40278-013-3062-5
(2013) Voriconazole. Reactions Weekly, 1451 (1) 49 doi:10.1007/s40278-013-3063-4
(2013) Warfarin. Reactions Weekly, 1451 (1) 49 doi:10.1007/s40278-013-3064-3
(2013) Zuclopenthixol. Reactions Weekly, 1451 (1) 50 doi:10.1007/s40278-013-3065-2

See Also

These are possibly similar items as determined by title/reference text matching only.

(2013, May) Reactions Weekly Vol. 1450 (1) Springer Science and Business Media LLC
(2013, May) Reactions Weekly Vol. 1452 (1) Springer Science and Business Media LLC
(2013, May) Reactions Weekly Vol. 1453 (1) Springer Science and Business Media LLC
(2018, May) Reactions Weekly Vol. 1700 (1) Springer Science and Business Media LLC
(2018, May) Reactions Weekly Vol. 1701 (1) Springer Science and Business Media LLC
(2018, May) Reactions Weekly Vol. 1702 (1) Springer Science and Business Media LLC
(2018, May) Reactions Weekly Vol. 1703 (1) Springer Science and Business Media LLC
(2019, May) Reactions Weekly Vol. 1751 (1) Springer Science and Business Media LLC
(2019, May) Reactions Weekly Vol. 1752 (1) Springer Science and Business Media LLC
(2019, May) Reactions Weekly Vol. 1753 (1) Springer Science and Business Media LLC
(2019, May) Reactions Weekly Vol. 1754 (1) Springer Science and Business Media LLC
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: August 15, 2025 06:04:35
Go to top of page